Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC SUVEN LIFE SCIENCES ALEMBIC/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 26.5 -14.7 - View Chart
P/BV x 0.8 14.3 5.5% View Chart
Dividend Yield % 2.4 0.0 -  

Financials

 ALEMBIC   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ALEMBIC
Mar-22
SUVEN LIFE SCIENCES
Mar-22
ALEMBIC/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs143124 115.2%   
Low Rs7270 102.2%   
Sales per share (Unadj.) Rs3.00.8 373.9%  
Earnings per share (Unadj.) Rs3.4-8.4 -40.0%  
Cash flow per share (Unadj.) Rs3.5-8.1 -43.8%  
Dividends per share (Unadj.) Rs1.800-  
Avg Dividend yield %1.70-  
Book value per share (Unadj.) Rs97.26.6 1,470.2%  
Shares outstanding (eoy) m256.78145.38 176.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x35.3119.6 29.6%   
Avg P/E ratio x32.1-11.6 -276.2%  
P/CF ratio (eoy) x30.4-12.0 -252.1%  
Price / Book Value ratio x1.114.7 7.5%  
Dividend payout %53.60-   
Avg Mkt Cap Rs m27,64314,164 195.2%   
No. of employees `000NANA-   
Total wages/salary Rs m215210 102.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m782118 660.4%  
Other income Rs m89253 1,677.3%   
Total revenues Rs m1,674172 975.5%   
Gross profit Rs m139-1,222 -11.4%  
Depreciation Rs m4944 110.7%   
Interest Rs m47 58.1%   
Profit before tax Rs m979-1,220 -80.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1170-   
Profit after tax Rs m862-1,220 -70.7%  
Gross profit margin %17.8-1,032.2 -1.7%  
Effective tax rate %11.90-   
Net profit margin %110.2-1,030.0 -10.7%  
BALANCE SHEET DATA
Current assets Rs m1,4331,605 89.3%   
Current liabilities Rs m6781,022 66.3%   
Net working cap to sales %96.6492.1 19.6%  
Current ratio x2.11.6 134.7%  
Inventory Days Days10,3461,402 738.0%  
Debtors Days Days710400 177.6%  
Net fixed assets Rs m24,886414 6,005.4%   
Share capital Rs m514145 353.3%   
"Free" reserves Rs m24,452816 2,996.3%   
Net worth Rs m24,966961 2,596.7%   
Long term debt Rs m00-   
Total assets Rs m26,3202,019 1,303.4%  
Interest coverage x252.6-181.1 -139.5%   
Debt to equity ratio x00-  
Sales to assets ratio x00.1 50.7%   
Return on assets %3.3-60.1 -5.5%  
Return on equity %3.5-126.9 -2.7%  
Return on capital %3.9-126.2 -3.1%  
Exports to sales %2.044.7 4.5%   
Imports to sales %0.3933.6 0.0%   
Exports (fob) Rs m1653 29.4%   
Imports (cif) Rs m21,106 0.2%   
Fx inflow Rs m1653 29.4%   
Fx outflow Rs m21,106 0.2%   
Net fx Rs m13-1,053 -1.3%   
CASH FLOW
From Operations Rs m-177-1,275 13.9%  
From Investments Rs m188-222 -84.8%  
From Financial Activity Rs m-581,457 -4.0%  
Net Cashflow Rs m-47-41 115.7%  

Share Holding

Indian Promoters % 70.9 65.0 109.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.0 0.6 825.0%  
FIIs % 0.8 0.5 172.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 35.0 83.2%  
Shareholders   83,612 80,116 104.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on ALEMBIC vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC vs Suven Life Sciences Share Price Performance

Period ALEMBIC Suven Life Sciences S&P BSE HEALTHCARE
1-Day 1.74% -0.32% -0.10%
1-Month 6.20% 3.61% -1.99%
1-Year -24.81% -30.60% -5.62%
3-Year CAGR 12.83% -37.98% 20.96%
5-Year CAGR 13.28% -19.91% 11.47%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of ALEMBIC hold a 70.9% stake in the company. In case of Suven Life Sciences the stake stands at 65.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 53.6%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ALEMBIC, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.